H. Lundbeck, Cipralex® approved by five European countries

Report this content

                        
Germany, Spain, Italy, Portugal and Finland today approved Cipralex® for the treatment of depression and panic disorders. Cipralex® has now been given approval in 26 countries, which account for approximately a combined 90 per cent of the global market for antidepressants.

Subscribe

Documents & Links